Seres Therapeutics Inc (MCRB)
0.8066
+0.01
(+1.45%)
USD |
NASDAQ |
Nov 05, 14:54
Seres Therapeutics Shareholders Equity (Quarterly): -87.07M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -87.07M |
| March 31, 2024 | -59.74M |
| December 31, 2023 | -44.86M |
| September 30, 2023 | -15.12M |
| June 30, 2023 | 22.61M |
| March 31, 2023 | -47.87M |
| December 31, 2022 | 10.78M |
| September 30, 2022 | 67.58M |
| June 30, 2022 | 23.06M |
| March 31, 2022 | 80.96M |
| December 31, 2021 | 131.51M |
| September 30, 2021 | 175.74M |
| June 30, 2021 | 101.07M |
| March 31, 2021 | 143.70M |
| December 31, 2020 | 174.75M |
| September 30, 2020 | 188.05M |
| June 30, 2020 | -65.58M |
| March 31, 2020 | -61.65M |
| December 31, 2019 | -48.32M |
| September 30, 2019 | -32.22M |
| Date | Value |
|---|---|
| June 30, 2019 | -17.97M |
| March 31, 2019 | -69.83M |
| December 31, 2018 | -48.04M |
| September 30, 2018 | -30.56M |
| June 30, 2018 | -13.26M |
| March 31, 2018 | 10.03M |
| December 31, 2017 | 60.70M |
| September 30, 2017 | 85.51M |
| June 30, 2017 | 87.93M |
| March 31, 2017 | 111.45M |
| December 31, 2016 | 132.63M |
| September 30, 2016 | 154.00M |
| June 30, 2016 | 167.40M |
| March 31, 2016 | 189.83M |
| December 31, 2015 | 205.39M |
| September 30, 2015 | 222.20M |
| June 30, 2015 | 94.91M |
| March 31, 2015 | 104.18M |
| December 31, 2014 | -26.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-87.07M
Minimum
Jun 2024
188.05M
Maximum
Sep 2020
36.29M
Average
22.61M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Chimerix Inc | 155.58M |
| Cellectar Biosciences Inc | 12.38M |
| Marinus Pharmaceuticals Inc | -47.34M |
| Jaguar Health Inc | 16.91M |
| PDS Biotechnology Corp | 30.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.73M |
| Total Liabilities (Quarterly) | 408.80M |